How pharmacies should adopt value- and performance-based payment models and offer DIR fee reductions for pharmacists’ and their patients’ benefit.
Payer education, evidence critical to providing cost-effective, beneficial treatment in pharmacogenetics.
CVS Pharmacy completes the rollout of time-delay safes for controlled substances in all of its North Carolina pharmacies to help reduce robbery incidents.
The strongest associations were found for broad-spectrum antibiotics and those that act against anaerobic bacteria and fungi, study suggests.
HOPE program can serve as a model for treating patients at risk for addiction.
Kootenai Care Network uses a population health management platform to reduce the burden on payers and providers.
Providing uniform and quality service to all patients, no matter their demographic.
The opioid crisis cost the U.S. billions. Find out the impact on the future economy.
Despite the trust between physicians and patients, some physicians believe another prescription drug crisis may arise.
First-of-its-kind survey brings clarity to the effect of 340B and Medicaid programs on each other through comprehensive state analysis.